Patents-Review.com
🔗 Permalink
Assignee profile:

Lupin Inc.

City:

Baltimore, Maryland

Country:

United States

Published Applications:

18

Last publication date:

2023-08-31

Patent Grants:

14

Last grant date:

2024-12-24

Top Inventors for applications by Lupin Inc.

These are the the leading inventors for applications assigned to Lupin Inc.:

Recent patent applications by Lupin Inc.

Lupin Inc. based in Baltimore, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-31
US20230270956A1
Human necessities

DOSE COUNTER ASSEMBLIES FOR MEDICAMENT DISPENSERS

 #2 | 2022-08-18 ✅ Patent 12,172,969 granted on 2024-12-24
US20220259156A1
Chemistry; metallurgy

Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof

 #3 | 2022-03-24 ✅ Patent 12,280,037 granted on 2025-04-22
US20220087978A1
Human necessities

Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

 #4 | 2021-09-16 ✅ Patent 11,684,607 granted on 2023-06-27
US20210283106A1
Human necessities

Secnidazole for use in the treatment of bacterial vaginosis

 #5 | 2021-08-26 ✅ Patent 11,602,522 granted on 2023-03-14
US20210260038A1
Human necessities

Secnidazole for use in the treatment of sexually transmitted infection

 #6 | 2021-05-27 ✅ Patent 11,478,503 granted on 2022-10-25
US20210154223A1
Human necessities

Vitamin B12 compound supplementation methods and compositions

 #7 | 2021-01-21
US20210015755A1
Human necessities

SECNIDAZOLE SOFT GELATIN CAPSULE AND METHODS AND USES THEREOF

 #8 | 2020-10-01 ✅ Patent 11,000,508 granted on 2021-05-11
US20200306228A1
Human necessities

Secnidazole for use in the treatment of trichomoniasis

 #9 | 2020-09-17 ✅ Patent 11,324,721 granted on 2022-05-10
US20200289470A1
Human necessities

Secnidazole for use in the treatment of trichomoniasis

 #10 | 2020-08-27 ✅ Patent 11,400,093 granted on 2022-08-02
US20200268756A1
Human necessities

Deuterated elagolix-like compositions and methods

 #11 | 2020-07-02 ✅ Patent 11,000,507 granted on 2021-05-11
US20200206192A1
Human necessities

Secnidazole for use in the treatment of bacterial vaginosis

 #12 | 2020-06-11
US20200179274A1
Human necessities

DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF

 #13 | 2020-03-05
US20200071279A1
Chemistry; metallurgy

DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF

 #14 | 2020-02-06 ✅ Patent 11,020,377 granted on 2021-06-01
US20200038372A1
Human necessities

Secnidazole for use in the treatment of bacterial vaginosis

 #15 | 2020-01-23 ✅ Patent 10,857,133 granted on 2020-12-08
US20200022958A1
Human necessities

Secnidazole for use in the treatment of bacterial vaginosis

 #16 | 2019-08-22 ✅ Patent 10,849,884 granted on 2020-12-01
US20190255020A1
Human necessities

Secnidazole for use in the treatment of bacterial vaginosis

 #17 | 2018-11-22 ✅ Patent 10,682,338 granted on 2020-06-16
US20180333391A1
Human necessities

Secnidazole for use in the treatment of bacterial vaginosis

 #18 | 2016-12-01 ✅ Patent 11,253,501 granted on 2022-02-22
US20160346252A1
Human necessities

Secnidazole formulations and use in treating bacterial vaginosis

Also check out LUPIN INC.'s (Baltimore, United States) applicant profile with 13 patent applications submitted.

AssigneeID:

155677 ⎘